NAICS 3254

Pharmaceutical & Medicine Manufacturing

Pharmaceutical and medicine manufacturing (NAICS 3254): U.S. drug production, biologics, and medicinal compounds. Industry overview, trends, and market analysis.

Published by VantaInsights Research·Methodology·Data Sources· AI-drafted
Built on data from Census Bureau CBP Bureau of Labor Statistics Federal Reserve FRED SEC EDGAR

Industry at a Glance

Sector-wide aggregates across all businesses classified under NAICS 3254 (2017 classification frame). For specific sub-industries within this sector, see the individual reports below.

Employment
321K
US Census CBP · 2023 · NAICS 2017
Establishments
2,905
US Census CBP · 2023 · NAICS 2017
Annual Payroll
$36.5B
US Census CBP · 2023 · NAICS 2017
Avg Annual Wage
$113,582
Derived from US Census CBP · 2023 · NAICS 2017
Market Size
$234.2B
US Census Economic Census · 2022 · NAICS 2017

Industry Overview

Pharmaceutical and medicine manufacturing (NAICS 3254) encompasses the production of pharmaceutical preparations, biological products, and medicinal compounds for human and veterinary use. This industry includes manufacturers of drugs in various forms—tablets, capsules, liquids, injectables, and biologics—as well as diagnostic substances and botanical pharmaceutical preparations. The industry represents a critical component of the broader chemical manufacturing sector and plays an essential role in the U.S. healthcare system, contributing significantly to GDP while supporting public health outcomes through the development and production of medications that treat diseases, manage chronic conditions, and prevent illness.

The pharmaceutical and medicine manufacturing industry is characterized by high barriers to entry, substantial research and development investments, stringent regulatory requirements, and the need for specialized scientific and manufacturing expertise. Companies operating in this space must navigate complex FDA approval processes, patent protection frameworks, and quality assurance standards including Good Manufacturing Practices (GMP). The industry serves diverse markets including retail pharmacies, hospitals, healthcare systems, government agencies, and direct-to-consumer channels, with products ranging from generic medications to novel biologics and specialty pharmaceuticals.

Key characteristics include significant consolidation among large integrated pharmaceutical manufacturers, a strong network of specialized contract manufacturers and smaller firms focused on novel product development, substantial capital requirements for facility development and regulatory compliance, and increasing pressure from pricing regulations and generic competition. The industry's performance is influenced by factors including healthcare policy changes, patent expiration cycles, clinical trial outcomes, FDA approval timelines, and international trade dynamics.

Who Uses These Reports

Trusted by professionals who need verified federal data to make decisions

Investors & PE Firms

Size markets, validate deal theses, and benchmark targets with verified federal data before committing capital

Consultants & Advisors

Deliver data-backed recommendations to clients with sourced and cited industry metrics — Census, BLS, and FRED

Founders & Operators

Validate market entry, benchmark against industry averages, and present credible data to investors and boards

Corporate Strategy Teams

Support expansion planning, M&A due diligence, and executive reporting with NAICS-classified industry data

See what's inside a report

Market sizing, workforce analysis, competitive landscape, regulatory environment — all sourced from Census, BLS, FRED, and SEC EDGAR.

Download a free sample report

Industry Trends

01

Accelerating adoption of continuous manufacturing and advanced process automation technologies to improve efficiency, reduce costs, and enhance product quality and consistency in pharmaceutical production facilities.

02

Increasing consolidation and strategic partnerships between large pharmaceutical manufacturers and contract manufacturing organizations (CMOs) to optimize production capacity and reduce operational costs amid pricing pressures.

03

Growing emphasis on personalized and precision medicine, including the development and manufacturing of targeted therapies, gene therapies, and individualized treatment approaches that require specialized manufacturing capabilities.

04

Rising investment in biosimilar and generic drug manufacturing capabilities as patent cliffs create market opportunities, with manufacturers expanding production of lower-cost alternatives to branded medications.

API

Strengthening supply chain resilience and domestic manufacturing capacity expansion driven by regulatory initiatives, national security concerns, and efforts to reduce dependence on international active pharmaceutical ingredient (API) suppliers.

Available Reports

1 industry report available for purchase under Pharmaceutical & Medicine Manufacturing.

Pharmaceutical Preparation Manufacturing
NAICS 325412
→

Specialty Reports Available on Request

4 specialty industriesavailable on request
▾
Medicinal & Botanical Manufacturing
325411View →
Pharmaceutical Preparation Manufacturing
325412Report →
In-vitro Diagnostic Substance Manufacturing
325413View →
Biological Product (Except Diagnostic) Manufacturing
325414View →

Industries

Browse deeper into the NAICS hierarchy.

325411 report

Pharmaceutical & Medicine Manufacturing

Frequently Asked Questions

What is NAICS 3254? ▾
NAICS 3254 is the industry classification for Pharmaceutical and Medicine Manufacturing in the United States. It includes establishments primarily engaged in manufacturing pharmaceutical preparations, medicinal chemicals, biological products, and in-vitro diagnostic substances for human and veterinary use. This classification falls under the broader Chemical Manufacturing sector (NAICS 325).
What is the difference between pharmaceutical manufacturers and contract manufacturers? ▾
Integrated pharmaceutical manufacturers (often called pharma companies) typically conduct their own research and development, obtain FDA approvals for new drugs, market branded medications, and own manufacturing facilities. Contract manufacturers (CMOs and CDMOs) provide manufacturing services on behalf of other companies, producing drugs according to specifications without conducting primary R&D or holding regulatory approvals themselves. Many pharmaceutical manufacturers partner with contract manufacturers to supplement their internal production capacity.
What regulatory requirements govern pharmaceutical manufacturing? ▾
Pharmaceutical manufacturers must comply with FDA regulations including Current Good Manufacturing Practice (CGMP) standards, maintain detailed quality control documentation, undergo facility inspections, and follow strict protocols for product testing, stability studies, and adverse event reporting. Additionally, manufacturers must obtain New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) approvals before marketing products, and comply with ongoing post-market surveillance and pharmacovigilance requirements.
How do generic and brand-name drug manufacturers differ operationally? ▾
Brand-name manufacturers invest heavily in research and development to discover and develop new chemical entities, conduct extensive clinical trials, and obtain initial FDA approvals, which provides patent protection and market exclusivity periods. Generic manufacturers typically begin production only after patent expiration, focusing on cost-efficient manufacturing of established formulations with proven safety and efficacy profiles, allowing them to offer significantly lower-priced alternatives.
What are the primary cost drivers in pharmaceutical manufacturing? ▾
Major cost factors include raw material and active pharmaceutical ingredient (API) procurement, facility construction and maintenance to meet GMP standards, quality control and testing, regulatory compliance and documentation, skilled labor for specialized manufacturing and QA roles, equipment depreciation for specialized production machinery, and research and development investments for larger integrated manufacturers.

Related Industries

Basic Chemical Manufacturing 3251Scientific Research & Development Services 5417Advertising, Public Relations, & Related Services 5418Offices of Physicians 6211Drugs & Druggists' Sundries Merchant Wholesalers 4242

Related Guides

industry-trends
Manufacturing Industry Trends: 2026 Data & Market Analysis

Get verified manufacturing industry trends data from federal sources. Total US Manufacturing Employment: 12.7M (Bureau of Labor Statistics, 2024).

Questions about how we source industry data? See our data sources FAQ.

Don't see your industry?

We can generate a report for any NAICS-classified industry in the US. Professional PDF delivered in 48 hours.

Request Custom ReportBrowse Marketplace